Insider Buying: Neonc Technologies (NASDAQ:NTHI) CEO Purchases $135,600.00 in Stock

Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) CEO Amir Heshmatpour purchased 40,000 shares of the stock in a transaction on Friday, November 6th. The shares were acquired at an average price of $3.39 per share, for a total transaction of $135,600.00. Following the transaction, the chief executive officer directly owned 3,253,000 shares of the company’s stock, valued at $11,027,670. This represents a 1.24% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Neonc Technologies Price Performance

Shares of NTHI opened at $4.52 on Thursday. Neonc Technologies Holdings, Inc. has a 12 month low of $2.50 and a 12 month high of $12.00. The stock’s 50 day moving average is $3.30 and its two-hundred day moving average is $5.31.

Neonc Technologies (NASDAQ:NTHI) last announced its earnings results on Thursday, November 5th. The company reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.25) by ($0.03).

Analyst Ratings Changes

A number of equities analysts have weighed in on the stock. Weiss Ratings cut shares of Neonc Technologies from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, October 21st. Zacks Research raised shares of Neonc Technologies from a “strong sell” rating to a “hold” rating in a report on Thursday, November 5th. Roth Capital started coverage on shares of Neonc Technologies in a research report on Thursday, September 24th. They issued a “buy” rating on the stock. Wall Street Zen raised shares of Neonc Technologies from a “sell” rating to a “hold” rating in a research note on Saturday, November 7th. Finally, BTIG Research reissued a “buy” rating and set a $15.00 target price on shares of Neonc Technologies in a research note on Tuesday, September 8th. Four equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Neonc Technologies has a consensus rating of “Moderate Buy” and an average target price of $16.00.

Hedge Funds Weigh In On Neonc Technologies

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Global Retirement Partners LLC purchased a new stake in shares of Neonc Technologies during the second quarter worth approximately $126,000. BlackRock Inc. acquired a new position in Neonc Technologies in the 2nd quarter valued at $815,000. Westmount Partners LLC lifted its holdings in Neonc Technologies by 355.2% in the 2nd quarter. Westmount Partners LLC now owns 197,178 shares of the company’s stock valued at $893,000 after purchasing an additional 153,858 shares in the last quarter. Finally, Bank of America Corp DE purchased a new position in Neonc Technologies in the 2nd quarter valued at $1,017,000.

About Neonc Technologies

NeOnc Technologies Holdings, Inc. is a biotechnology company developing treatments for brain tumors and other central nervous system cancers. Its research focuses on approaches intended to deliver therapies to the brain, where the blood-brain barrier can limit the effectiveness of conventional treatments. The company’s pipeline includes NEO100, a formulation of perillyl alcohol designed for intranasal delivery, and NEO212, a compound combining perillyl alcohol with temozolomide. These candidates are being developed for potential use in brain cancer treatment.